13F filer · CIK 914208 ↗
Invesco Ltd.
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$341.42B
+9.9% on the quarter before
Positions
4,013
168 new · 137 sold out
Top 10
10.4%
of the value
Est. gain
+$24.93B
on stocks held all quarter
Est. return
+8.6%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Invesco Ltd.'s 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 17% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$336.4MAdded · 0.4% → 0.5%+2,301,569 shares
- Visa Inc.~$287.4MAdded · 0.6% → 0.7%+1,383,548 shares
- Union Pac Corp~$279.4MAdded · 0.2% → 0.3%+1,349,438 shares
- Microsoft~$276.8MAdded · 2.4% → 2.3%+1,154,354 shares
- Mastercard~$260.5MAdded · 0.3% → 0.4%+749,266 shares
- Accenture Plc Ireland~$250.0MAdded · 0.2% → 0.2%+937,049 shares
- Svb Financial Group~$245.7MAdded · 0.1% → 0.1%+1,067,727 shares
- Dominion Energy~$244.2MAdded · 0.2% → 0.2%+3,982,051 shares
- Brookfield Corp~$217.2MNew · 0.0% → 0.1%+6,902,512 shares
- Kkr & Co Inc~$178.3MAdded · 0.1% → 0.1%+3,841,034 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Unitedhealth Group Inc~$440.8MCut · 0.9% → 0.8%−831,376 shares
- Cognizant~$272.9MCut · 0.3% → 0.2%−4,771,163 shares
- Bristol-Myers Squibb Co~$267.9MCut · 0.4% → 0.3%−3,723,858 shares
- Brookfield Asset Mgmt Inc~$264.8MSold out · 0.1% → 0.0%−6,475,922 shares
- Eli Lilly~$262.5MCut · 0.5% → 0.4%−717,500 shares
- Palo Alto Networks~$245.7MCut · 0.2% → 0.0%−1,760,963 shares
- Procter And Gamble Co~$242.8MCut · 0.3% → 0.3%−1,601,862 shares
- Corteva Inc~$223.2MCut · 0.2% → 0.1%−3,796,584 shares
- Elevance Health Inc~$217.0MCut · 0.4% → 0.4%−422,994 shares
- Lpl Finl Hldgs Inc~$215.1MCut · 0.1% → 0.0%−994,890 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +3.6% · price +3.0% | 2.3% | $7.95B | +$221.3M | ||||||||
| AppleCOM · shares −1.8% · price −6.0% | 1.7% | $5.83B | −$371.4M | ||||||||
| AlphabetCAP STK CL A · shares −2.6% · price −7.8% | 1.1% | $3.73B | −$313.4M | ||||||||
| AmazonCOM · shares −0.4% · price −25.7% | 0.97% | $3.30B | −$1.14B | ||||||||
| Exxon Mobil CorpCOM · shares +2.4% · price +26.3% | 0.83% | $2.84B | +$577.4M | ||||||||
| Unitedhealth Group IncCOM · shares −15% · price +5.0% | 0.76% | $2.59B | +$122.9M | ||||||||
| Chevron Corp NewCOM · shares −5.4% · price +24.9% | 0.75% | $2.55B | +$508.4M | ||||||||
| Visa Inc.COM CL A · shares +13% · price +16.9% | 0.72% | $2.46B | +$315.0M | ||||||||
| Johnson & JohnsonCOM · shares −5.9% · price +8.1% | 0.65% | $2.23B | +$167.7M | ||||||||
| Yum China Hldgs IncCOM · shares −1.0% · price +15.5% | 0.64% | $2.18B | +$292.5M | ||||||||
| MetaCL A · shares +3.8% · price −11.3% | 0.62% | $2.11B | −$259.5M | ||||||||
| Merck & Co IncCOM · shares +1.5% · price +28.8% | 0.58% | $1.99B | +$438.3M | ||||||||
| Bank America CorpCOM · shares +2.7% · price +9.7% | 0.56% | $1.90B | +$163.3M | ||||||||
| Jpmorgan Chase & CoCOM · shares +3.3% · price +28.3% | 0.54% | $1.85B | +$395.6M | ||||||||
| NvidiaCOM · shares +23% · price +20.4% | 0.53% | $1.80B | +$247.5M | ||||||||
| ConocophillipsCOM · shares −1.4% · price +15.3% | 0.51% | $1.73B | +$229.9M | ||||||||
| Wells Fargo Co NewCOM · shares −5.0% · price +2.7% | 0.49% | $1.69B | +$43.7M | ||||||||
| Coca Cola CoCOM · shares −8.6% · price +13.5% | 0.47% | $1.61B | +$192.4M | ||||||||
| IntuitCOM · shares +4.4% · price +0.5% | 0.45% | $1.53B | +$7.2M | ||||||||
| Eli LillyCOM · shares −15% · price +13.1% | 0.44% | $1.51B | +$175.9M | ||||||||
| Analog DevicesCOM · shares +2.7% · price +17.7% | 0.44% | $1.51B | +$221.8M | ||||||||
| Cvs Health CorpCOM · shares −8.6% · price −2.3% | 0.43% | $1.46B | −$34.2M | ||||||||
| Abbvie IncCOM · shares +6.2% · price +20.4% | 0.43% | $1.45B | +$232.2M | ||||||||
| AlphabetCAP STK CL C · shares +7.2% · price −7.7% | 0.42% | $1.44B | −$112.5M | ||||||||
| BroadcomCOM · shares −1.2% · price +25.9% | 0.42% | $1.44B | +$296.6M | ||||||||
| Total · 4,013 positions | 100% | $341.42B | +$24.93B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 3,695 stocks held throughout, up $24.93B (+8.6%).
- Exxon Mobil Corp+$577.4M+26%
- Chevron Corp New+$508.4M+25%
- Merck & Co Inc+$438.3M+29%
- Jpmorgan Chase & Co+$395.6M+28%
- Visa Inc.+$315.0M+17%
- Meta−$259.5M−11%
- Alphabet−$313.4M−8%
- Apple−$371.4M−6%
- Tesla−$1.01B−54%
- Amazon−$1.14B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $1.26T+23% | SEC ↗ |
| Q1 2026 | May 12, 2026 (amended) | $1.02T−3% | SEC ↗ |
| Q4 2025 | Feb 19, 2026 (amended) | $1.06T+67% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $634.72B+8% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $587.99B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $527.93B−2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $540.90B+4% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $517.95B+10% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $472.84B+2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $465.56B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $420.24B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $371.30B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $381.45B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $358.48B+5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $341.42B+10% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $310.69B−6% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $330.04B−16% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $392.05B−5% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $414.84B+5% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $394.59B−3% | SEC ↗ |
| Q2 2021 | Aug 17, 2021 | $406.58B+9% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $374.71B+9% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $343.59B+16% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $295.82B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $279.68B+18% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $237.58B−26% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $322.08B−16% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $382.36B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 (amended) | $388.53B+31% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $296.53B+14% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $261.24B−18% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $317.79B+5% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $302.15B+13% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $267.56B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $277.31B+2% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.72B−16% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $321.34B+5% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $304.59B+2% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $297.54B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $291.04B+7% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $272.23B+11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $246.04B | SEC ↗ |